Literature DB >> 2028925

Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature.

D Sharma1, G Flora, S M Grunberg.   

Abstract

Merkel cell carcinoma is a skin cancer that bears histologic, ultrastructural, and immunohistochemical resemblance to small cell lung cancer. Although this tumor is often localized and may be treated with wide excision, metastatic Merkel cell carcinoma does appear in 18%-28% of patients and may be aggressive and lethal. We report a case of metastatic Merkel cell carcinoma who responded to treatment with cisplatin/etoposide. Review of the literature reveals that doxorubicin/cyclophosphamide-based regimens and cisplatin-based regimens have been most commonly studied. Complete and partial responses are often achieved although the duration of response tends to be short. Further investigation of chemotherapeutic regimens similar to those used in small cell lung cancer should be undertaken.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028925     DOI: 10.1097/00000421-199104000-00014

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  19 in total

1.  Brain metastasis of Merkel cell carcinoma.

Authors:  M Turgut
Journal:  Neurosurg Rev       Date:  2002-03       Impact factor: 3.042

2.  Effect of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against human Merkel cell carcinoma MKL-1 cells.

Authors:  Zhenyu Lin; Hong Mei; Jiquan Fan; Zhongyuan Yin; Gang Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

3.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Authors:  Howard L Kaufman; Jeffery Russell; Omid Hamid; Shailender Bhatia; Patrick Terheyden; Sandra P D'Angelo; Kent C Shih; Céleste Lebbé; Gerald P Linette; Michele Milella; Isaac Brownell; Karl D Lewis; Jochen H Lorch; Kevin Chin; Lisa Mahnke; Anja von Heydebreck; Jean-Marie Cuillerot; Paul Nghiem
Journal:  Lancet Oncol       Date:  2016-09-01       Impact factor: 41.316

4.  The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.

Authors:  Todd C Knepper; Meagan Montesion; Jeffery S Russell; Ethan S Sokol; Garrett M Frampton; Vincent A Miller; Lee A Albacker; Howard L McLeod; Zeynep Eroglu; Nikhil I Khushalani; Vernon K Sondak; Jane L Messina; Michael J Schell; James A DeCaprio; Kenneth Y Tsai; Andrew S Brohl
Journal:  Clin Cancer Res       Date:  2019-08-09       Impact factor: 12.531

5.  Neurologic complications of Merkel cell carcinoma.

Authors:  S M Snodgrass; H Landy; A M Markoe; L Feun
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Surgical management of Merkel cell carcinoma.

Authors:  P J Allen; Z F Zhang; D G Coit
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

7.  G3139 (Genasense) in patients with advanced merkel cell carcinoma.

Authors:  Manisha H Shah; Kimberly A Varker; Minden Collamore; James A Zwiebel; Daniel Coit; David Kelsen; Ki Y Chung
Journal:  Am J Clin Oncol       Date:  2009-04       Impact factor: 2.339

8.  Merkel cell carcinoma: a retrospective study on 48 cases and review of literature.

Authors:  Fernando Cirillo; Marco Vismarra; Ines Cafaro; Mario Martinotti
Journal:  J Oncol       Date:  2012-09-13       Impact factor: 4.375

9.  Clinical emergence of neurometastatic merkel cell carcinoma: a surgical case series and literature review.

Authors:  Thomasina L Bailey; Maxwell A Fung; Regina Gandour-Edwards; William G Ellis; Rudolph J Schrot
Journal:  J Neurooncol       Date:  2010-07-29       Impact factor: 4.130

10.  Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 12.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.